Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Alemtuzumab in multiple sclerosis: an update.
Nurr1 reduction influences the onset of chronic EAE in mice.
Prediction of disability progression in fingolimod-treated patients.
Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
Literature Commentary.
Effects of particulate matter exposure on multiple sclerosis hospital admission in Lombardy region, Italy.
The Efficacy of Primidone in Reducing Severe Cerebellar Tremors in Patients With Multiple Sclerosis.
Protein kinase C polymorphisms and vitamin D levels in multiple sclerosis.
Plasma levels of neuron specific enolase quantify the extent of neuronal injury in murine models of ischemic stroke and multiple sclerosis.
Nonlinear dynamical structure of sway path during standing in patients with multiple sclerosis and in healthy controls is affected by changes in sensory input and cognitive load.
Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis.
Tropical myelopathies.
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis.
CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4.
Obesity and HLA in multiple sclerosis: Weighty matters.
Natalizumab: Bench to Bedside and Beyond.
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
Experimental and therapeutic opportunities for stem cells in multiple sclerosis.
The relationship between muscle pain and fatigue.
Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
P wave duration and dispersion and QT interval in multiple sclerosis.
Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction.
Prediction of disease severity in neuromyelitis optica by the levels of IL-6 produced during remission phase.
Antigen-Specific Binding of Multivalent Soluble Antigen Arrays Induces Receptor Clustering and Impedes B Cell Receptor Mediated Signaling.
Unusual Manifestations of Pediatric Neuromyelitis Optica.

Pages